University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 0S-01-17


 
Description: Tumor Tissue Collection for Molecular Determinants in Patients with Cancer Treated with Gemcitabine-Based Chemotherapy.
Status: Open
Randomized? No


Researchers  
Principal InvestigatorTitle
Heinz Josef LenzM.D.

Data Management
NameTitle
Ramona LujanR.N.
Mileidys GomezD.M.


You may participate in this study if:
 Requirement
1Any patient >18 years old with histologically confirmed cancer who will receive gemzar-based chemotherapy.
2Prior chemotherapy is allowed.
3Only patients who have tumor tissue are included. Only already collected tumor tissue in the form of fresh frozen or paraffin-embedded tumor tissue will be used. The tumor tissue should be collected prior to start of gemzar chemotherapy.
4Signed informed consent.


You may not participate in this study if:
1Prior gemzar therapy.
2Patients with limited amount of tumor tissue available for diagnostic purposes.


For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.